ESSA Pharma (EPIX) Expected to Announce Earnings on Tuesday

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) will likely be announcing its earnings results before the market opens on Tuesday, February 11th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter.

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) last issued its quarterly earnings results on Tuesday, December 17th. The company reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.05. On average, analysts expect ESSA Pharma to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

ESSA Pharma Stock Down 0.6 %

Shares of NASDAQ EPIX opened at $1.69 on Monday. The business has a fifty day simple moving average of $1.72 and a 200-day simple moving average of $3.71. The company has a market cap of $75.02 million, a price-to-earnings ratio of -2.64 and a beta of 1.60. ESSA Pharma has a 12 month low of $1.40 and a 12 month high of $10.97.

Analyst Ratings Changes

A number of equities analysts recently commented on EPIX shares. Piper Sandler lowered shares of ESSA Pharma from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $15.00 to $2.00 in a research note on Monday, November 4th. Oppenheimer cut ESSA Pharma from an “outperform” rating to a “market perform” rating in a research note on Monday, November 4th. Finally, Jefferies Financial Group lowered shares of ESSA Pharma from a “buy” rating to a “hold” rating in a research report on Monday, November 4th.

About ESSA Pharma

ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.